Welcome to LookChem.com Sign In|Join Free
  • or
C13H17FN2O2 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1255762-99-2

Post Buying Request

1255762-99-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1255762-99-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1255762-99-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,5,7,6 and 2 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1255762-99:
(9*1)+(8*2)+(7*5)+(6*5)+(5*7)+(4*6)+(3*2)+(2*9)+(1*9)=182
182 % 10 = 2
So 1255762-99-2 is a valid CAS Registry Number.

1255762-99-2Downstream Products

1255762-99-2Relevant academic research and scientific papers

PREPARATION OF LABELLED COMPOUNDS

-

Page/Page column 101-102, (2010/12/18)

The invention relates to a process for producing a labelled compound, which process comprises treating a compound of formula (I), wherein X is a moiety to be labelled or a detectable label, and R1, R2, R3 and R4 are substitutent groups as defined herein; with a compound of formula (II) : N3-L-Y (π) wherein Y is a detectable label or a moiety to be labelled, provided that if X in the compound of formula (I) is a moiety to be labelled, then Y is a detectable label and if X in the compound of formula (I) is a detectable label, then Y is a moiety to be labelled; and L is a bond or a linking group, thereby producing a labelled compound of formula (IH) by Staudinger Ligation. Groups R3 and R4 may comprise fluorous moieties, in order to facilitate purification of the labelled compound of formula (IH). The invention also provides methods of imaging a human or non-human patient or a cell or in vitro sample, using the labelled compound of formula (III) thus produced, as well as imaging methods in which the compounds of formulae (I) and (II) are administered to the patient, cell or sample. The invention further provides novel compounds of formula (I) and formula (III), a process for producing the compounds of formula (T), and a combination product for medical imaging comprising a compound of formula (I) and a compound of formula (II).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1255762-99-2